Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

They've started to offer, instead of just the auto injector pens ... but also targets glucagon. That's the triple-G. That's going to read out later this year, and what we've seen so far is ...

It is an injection that contains a combination of long-acting insulin and a glucagon-like peptide ... It comes in an auto-injector pen with a pre-attached, hidden needle that doesn't need to ...

The subjects were then given glucagon-free insulin intravenously ... 10 Plasma glucose was measured in an Auto-Analyzer. Only patients and subjects whose blood sugar level dropped below 45 ...

Glucagon-like peptide-1 (GLP-1) are medications that help lower blood sugar levels and promote weight loss. Liraglutide is a synthetic analog of GLP-1 peptide and is administered as a once-daily ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

and GLP-1 (glucagon-like peptide-1) hormone receptors which eventually help with obesity, overweight and type 2 diabetes. According to the company, the injection is supposed to be taken once every ...

More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.